Evaluation of therapeutics management patterns and glycemic control of pediatric type 1 diabetes mellitus patients in Turkey: A nationwide cross-sectional study

Highlights • Basal bolus insulin injection (BBI) insulin therapy is widely used among pediatric T1DM patients in our country. • Taking carbohydrate count and insulin correction dose into consideration had positive impact on the metabolic control. Therefore, promoting the use of carbohydrate count an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes research and clinical practice 2016-09, Vol.119, p.32-40
Hauptverfasser: Hatun, Şükrü, Demirbilek, Hüseyin, Darcan, Şükran, Yüksel, Ayşegül, Binay, Cigdem, Şimşek, Damla Gökşen, Kara, Cengiz, Çetinkaya, Ergun, Ünüvar, Tolga, Uçaktürk, Ahmet, Tütüncüler, Filiz, Cesur, Yaşar, Bundak, Ruveyde, Saglam, Halil, Simsek, Enver, Bereket, Abdullah
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 40
container_issue
container_start_page 32
container_title Diabetes research and clinical practice
container_volume 119
creator Hatun, Şükrü
Demirbilek, Hüseyin
Darcan, Şükran
Yüksel, Ayşegül
Binay, Cigdem
Şimşek, Damla Gökşen
Kara, Cengiz
Çetinkaya, Ergun
Ünüvar, Tolga
Uçaktürk, Ahmet
Tütüncüler, Filiz
Cesur, Yaşar
Bundak, Ruveyde
Saglam, Halil
Simsek, Enver
Bereket, Abdullah
description Highlights • Basal bolus insulin injection (BBI) insulin therapy is widely used among pediatric T1DM patients in our country. • Taking carbohydrate count and insulin correction dose into consideration had positive impact on the metabolic control. Therefore, promoting the use of carbohydrate count and insulin correction doses may potentially improve the metabolic outcome. • Despite improvement in the treatment facilities and diabetic care, metabolic control is not at a satisfactory level in our country. • New and comprehensive initiatives require for patients with poor metabolic control, particularly a special care for the HbA1c >10%(86mmol/mol) level group.
doi_str_mv 10.1016/j.diabres.2016.04.059
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1812224016</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168822716301759</els_id><sourcerecordid>1812224016</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-b9d8c63d61e32208e065277a319b70ab0291f482e441b0c45cb737522f6e234c3</originalsourceid><addsrcrecordid>eNqFUsFu1DAQtVAR3RY-AeRjLwm248RZDq2qqgWkShwoZ8txJsVL4gTbaZW_4VOZ7C4cuHCyPZ558-a9IeQtZzlnvHq_y1tnmgAxF_jMmcxZuX1BNrxWIquFUCdkgx_1_n5KzmLcMcaqQpavyKlQUhRM8Q35dftk-tkkN3o6djR9h2AmmJOzkQ7Gm0cYwCc6mZQg-EiNb-ljv1gYnKV29CmM_Vo4AdJJAYNpmYByurKDBIgCfe_SHFcMh1iROk8f5vADlg_0mvp972fXArVhjDGLYNeI6WlMc7u8Ji8700d4czzPybe724ebT9n9l4-fb67vMysFS1mzbWtbFW3FoRCC1cCqUihlCr5tFDMNE1veyVqAlLxhVpa2UYUqhegqEIW0xTm5OOBOYfw5Q0x6cNEid-NhnKPmNRdCSJQUU8tD6p5wgE5PwQ0mLJozvZqjd_pojl7N0UxqNAfr3h1bzM0A7d-qP25gwtUhAXDQJwdBR4uSWdQ2oCq6Hd1_W1z-g2B75501PcoNcTfOAZXFaXQUmumv64asC4JTMa4Q4Dfs4LrG</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1812224016</pqid></control><display><type>article</type><title>Evaluation of therapeutics management patterns and glycemic control of pediatric type 1 diabetes mellitus patients in Turkey: A nationwide cross-sectional study</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Hatun, Şükrü ; Demirbilek, Hüseyin ; Darcan, Şükran ; Yüksel, Ayşegül ; Binay, Cigdem ; Şimşek, Damla Gökşen ; Kara, Cengiz ; Çetinkaya, Ergun ; Ünüvar, Tolga ; Uçaktürk, Ahmet ; Tütüncüler, Filiz ; Cesur, Yaşar ; Bundak, Ruveyde ; Saglam, Halil ; Simsek, Enver ; Bereket, Abdullah</creator><creatorcontrib>Hatun, Şükrü ; Demirbilek, Hüseyin ; Darcan, Şükran ; Yüksel, Ayşegül ; Binay, Cigdem ; Şimşek, Damla Gökşen ; Kara, Cengiz ; Çetinkaya, Ergun ; Ünüvar, Tolga ; Uçaktürk, Ahmet ; Tütüncüler, Filiz ; Cesur, Yaşar ; Bundak, Ruveyde ; Saglam, Halil ; Simsek, Enver ; Bereket, Abdullah ; Turkish Pediatric Diabetes Research Group</creatorcontrib><description>Highlights • Basal bolus insulin injection (BBI) insulin therapy is widely used among pediatric T1DM patients in our country. • Taking carbohydrate count and insulin correction dose into consideration had positive impact on the metabolic control. Therefore, promoting the use of carbohydrate count and insulin correction doses may potentially improve the metabolic outcome. • Despite improvement in the treatment facilities and diabetic care, metabolic control is not at a satisfactory level in our country. • New and comprehensive initiatives require for patients with poor metabolic control, particularly a special care for the HbA1c &gt;10%(86mmol/mol) level group.</description><identifier>ISSN: 0168-8227</identifier><identifier>EISSN: 1872-8227</identifier><identifier>DOI: 10.1016/j.diabres.2016.04.059</identifier><identifier>PMID: 27423071</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Adolescent ; Blood Glucose - analysis ; Child ; Child, Preschool ; Children ; Cross-Sectional Studies ; Diabetes Mellitus, Type 1 - drug therapy ; Disease Management ; Endocrinology &amp; Metabolism ; Female ; Glycated Hemoglobin A - analysis ; Glycemic control ; HbA1c ; Humans ; Infant ; Male ; Treatment ; Turkey ; Type 1 diabetes</subject><ispartof>Diabetes research and clinical practice, 2016-09, Vol.119, p.32-40</ispartof><rights>2016 Elsevier Ireland Ltd</rights><rights>Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-b9d8c63d61e32208e065277a319b70ab0291f482e441b0c45cb737522f6e234c3</citedby><cites>FETCH-LOGICAL-c420t-b9d8c63d61e32208e065277a319b70ab0291f482e441b0c45cb737522f6e234c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.diabres.2016.04.059$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27423071$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hatun, Şükrü</creatorcontrib><creatorcontrib>Demirbilek, Hüseyin</creatorcontrib><creatorcontrib>Darcan, Şükran</creatorcontrib><creatorcontrib>Yüksel, Ayşegül</creatorcontrib><creatorcontrib>Binay, Cigdem</creatorcontrib><creatorcontrib>Şimşek, Damla Gökşen</creatorcontrib><creatorcontrib>Kara, Cengiz</creatorcontrib><creatorcontrib>Çetinkaya, Ergun</creatorcontrib><creatorcontrib>Ünüvar, Tolga</creatorcontrib><creatorcontrib>Uçaktürk, Ahmet</creatorcontrib><creatorcontrib>Tütüncüler, Filiz</creatorcontrib><creatorcontrib>Cesur, Yaşar</creatorcontrib><creatorcontrib>Bundak, Ruveyde</creatorcontrib><creatorcontrib>Saglam, Halil</creatorcontrib><creatorcontrib>Simsek, Enver</creatorcontrib><creatorcontrib>Bereket, Abdullah</creatorcontrib><creatorcontrib>Turkish Pediatric Diabetes Research Group</creatorcontrib><title>Evaluation of therapeutics management patterns and glycemic control of pediatric type 1 diabetes mellitus patients in Turkey: A nationwide cross-sectional study</title><title>Diabetes research and clinical practice</title><addtitle>Diabetes Res Clin Pract</addtitle><description>Highlights • Basal bolus insulin injection (BBI) insulin therapy is widely used among pediatric T1DM patients in our country. • Taking carbohydrate count and insulin correction dose into consideration had positive impact on the metabolic control. Therefore, promoting the use of carbohydrate count and insulin correction doses may potentially improve the metabolic outcome. • Despite improvement in the treatment facilities and diabetic care, metabolic control is not at a satisfactory level in our country. • New and comprehensive initiatives require for patients with poor metabolic control, particularly a special care for the HbA1c &gt;10%(86mmol/mol) level group.</description><subject>Adolescent</subject><subject>Blood Glucose - analysis</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Cross-Sectional Studies</subject><subject>Diabetes Mellitus, Type 1 - drug therapy</subject><subject>Disease Management</subject><subject>Endocrinology &amp; Metabolism</subject><subject>Female</subject><subject>Glycated Hemoglobin A - analysis</subject><subject>Glycemic control</subject><subject>HbA1c</subject><subject>Humans</subject><subject>Infant</subject><subject>Male</subject><subject>Treatment</subject><subject>Turkey</subject><subject>Type 1 diabetes</subject><issn>0168-8227</issn><issn>1872-8227</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUsFu1DAQtVAR3RY-AeRjLwm248RZDq2qqgWkShwoZ8txJsVL4gTbaZW_4VOZ7C4cuHCyPZ558-a9IeQtZzlnvHq_y1tnmgAxF_jMmcxZuX1BNrxWIquFUCdkgx_1_n5KzmLcMcaqQpavyKlQUhRM8Q35dftk-tkkN3o6djR9h2AmmJOzkQ7Gm0cYwCc6mZQg-EiNb-ljv1gYnKV29CmM_Vo4AdJJAYNpmYByurKDBIgCfe_SHFcMh1iROk8f5vADlg_0mvp972fXArVhjDGLYNeI6WlMc7u8Ji8700d4czzPybe724ebT9n9l4-fb67vMysFS1mzbWtbFW3FoRCC1cCqUihlCr5tFDMNE1veyVqAlLxhVpa2UYUqhegqEIW0xTm5OOBOYfw5Q0x6cNEid-NhnKPmNRdCSJQUU8tD6p5wgE5PwQ0mLJozvZqjd_pojl7N0UxqNAfr3h1bzM0A7d-qP25gwtUhAXDQJwdBR4uSWdQ2oCq6Hd1_W1z-g2B75501PcoNcTfOAZXFaXQUmumv64asC4JTMa4Q4Dfs4LrG</recordid><startdate>20160901</startdate><enddate>20160901</enddate><creator>Hatun, Şükrü</creator><creator>Demirbilek, Hüseyin</creator><creator>Darcan, Şükran</creator><creator>Yüksel, Ayşegül</creator><creator>Binay, Cigdem</creator><creator>Şimşek, Damla Gökşen</creator><creator>Kara, Cengiz</creator><creator>Çetinkaya, Ergun</creator><creator>Ünüvar, Tolga</creator><creator>Uçaktürk, Ahmet</creator><creator>Tütüncüler, Filiz</creator><creator>Cesur, Yaşar</creator><creator>Bundak, Ruveyde</creator><creator>Saglam, Halil</creator><creator>Simsek, Enver</creator><creator>Bereket, Abdullah</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160901</creationdate><title>Evaluation of therapeutics management patterns and glycemic control of pediatric type 1 diabetes mellitus patients in Turkey: A nationwide cross-sectional study</title><author>Hatun, Şükrü ; Demirbilek, Hüseyin ; Darcan, Şükran ; Yüksel, Ayşegül ; Binay, Cigdem ; Şimşek, Damla Gökşen ; Kara, Cengiz ; Çetinkaya, Ergun ; Ünüvar, Tolga ; Uçaktürk, Ahmet ; Tütüncüler, Filiz ; Cesur, Yaşar ; Bundak, Ruveyde ; Saglam, Halil ; Simsek, Enver ; Bereket, Abdullah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-b9d8c63d61e32208e065277a319b70ab0291f482e441b0c45cb737522f6e234c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adolescent</topic><topic>Blood Glucose - analysis</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Cross-Sectional Studies</topic><topic>Diabetes Mellitus, Type 1 - drug therapy</topic><topic>Disease Management</topic><topic>Endocrinology &amp; Metabolism</topic><topic>Female</topic><topic>Glycated Hemoglobin A - analysis</topic><topic>Glycemic control</topic><topic>HbA1c</topic><topic>Humans</topic><topic>Infant</topic><topic>Male</topic><topic>Treatment</topic><topic>Turkey</topic><topic>Type 1 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hatun, Şükrü</creatorcontrib><creatorcontrib>Demirbilek, Hüseyin</creatorcontrib><creatorcontrib>Darcan, Şükran</creatorcontrib><creatorcontrib>Yüksel, Ayşegül</creatorcontrib><creatorcontrib>Binay, Cigdem</creatorcontrib><creatorcontrib>Şimşek, Damla Gökşen</creatorcontrib><creatorcontrib>Kara, Cengiz</creatorcontrib><creatorcontrib>Çetinkaya, Ergun</creatorcontrib><creatorcontrib>Ünüvar, Tolga</creatorcontrib><creatorcontrib>Uçaktürk, Ahmet</creatorcontrib><creatorcontrib>Tütüncüler, Filiz</creatorcontrib><creatorcontrib>Cesur, Yaşar</creatorcontrib><creatorcontrib>Bundak, Ruveyde</creatorcontrib><creatorcontrib>Saglam, Halil</creatorcontrib><creatorcontrib>Simsek, Enver</creatorcontrib><creatorcontrib>Bereket, Abdullah</creatorcontrib><creatorcontrib>Turkish Pediatric Diabetes Research Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes research and clinical practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hatun, Şükrü</au><au>Demirbilek, Hüseyin</au><au>Darcan, Şükran</au><au>Yüksel, Ayşegül</au><au>Binay, Cigdem</au><au>Şimşek, Damla Gökşen</au><au>Kara, Cengiz</au><au>Çetinkaya, Ergun</au><au>Ünüvar, Tolga</au><au>Uçaktürk, Ahmet</au><au>Tütüncüler, Filiz</au><au>Cesur, Yaşar</au><au>Bundak, Ruveyde</au><au>Saglam, Halil</au><au>Simsek, Enver</au><au>Bereket, Abdullah</au><aucorp>Turkish Pediatric Diabetes Research Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of therapeutics management patterns and glycemic control of pediatric type 1 diabetes mellitus patients in Turkey: A nationwide cross-sectional study</atitle><jtitle>Diabetes research and clinical practice</jtitle><addtitle>Diabetes Res Clin Pract</addtitle><date>2016-09-01</date><risdate>2016</risdate><volume>119</volume><spage>32</spage><epage>40</epage><pages>32-40</pages><issn>0168-8227</issn><eissn>1872-8227</eissn><abstract>Highlights • Basal bolus insulin injection (BBI) insulin therapy is widely used among pediatric T1DM patients in our country. • Taking carbohydrate count and insulin correction dose into consideration had positive impact on the metabolic control. Therefore, promoting the use of carbohydrate count and insulin correction doses may potentially improve the metabolic outcome. • Despite improvement in the treatment facilities and diabetic care, metabolic control is not at a satisfactory level in our country. • New and comprehensive initiatives require for patients with poor metabolic control, particularly a special care for the HbA1c &gt;10%(86mmol/mol) level group.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>27423071</pmid><doi>10.1016/j.diabres.2016.04.059</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0168-8227
ispartof Diabetes research and clinical practice, 2016-09, Vol.119, p.32-40
issn 0168-8227
1872-8227
language eng
recordid cdi_proquest_miscellaneous_1812224016
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adolescent
Blood Glucose - analysis
Child
Child, Preschool
Children
Cross-Sectional Studies
Diabetes Mellitus, Type 1 - drug therapy
Disease Management
Endocrinology & Metabolism
Female
Glycated Hemoglobin A - analysis
Glycemic control
HbA1c
Humans
Infant
Male
Treatment
Turkey
Type 1 diabetes
title Evaluation of therapeutics management patterns and glycemic control of pediatric type 1 diabetes mellitus patients in Turkey: A nationwide cross-sectional study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T13%3A01%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20therapeutics%20management%20patterns%20and%20glycemic%20control%20of%20pediatric%20type%201%20diabetes%20mellitus%20patients%20in%20Turkey:%20A%20nationwide%20cross-sectional%20study&rft.jtitle=Diabetes%20research%20and%20clinical%20practice&rft.au=Hatun,%20%C5%9E%C3%BCkr%C3%BC&rft.aucorp=Turkish%20Pediatric%20Diabetes%20Research%20Group&rft.date=2016-09-01&rft.volume=119&rft.spage=32&rft.epage=40&rft.pages=32-40&rft.issn=0168-8227&rft.eissn=1872-8227&rft_id=info:doi/10.1016/j.diabres.2016.04.059&rft_dat=%3Cproquest_cross%3E1812224016%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1812224016&rft_id=info:pmid/27423071&rft_els_id=S0168822716301759&rfr_iscdi=true